CERVOMED INC (CRVO)
(Delayed Data from NSDQ)
$7.79 USD
-0.31 (-3.83%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $7.80 +0.01 (0.13%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, CervoMed Inc. has a market cap of $74.95M, which represents its share price of $8.10 multiplied by its outstanding shares number of 9.25M. As a small-cap company, CRVO's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
CRVO 7.79 -0.31(-3.83%)
Will CRVO be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for CRVO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CRVO
Sangamo Therapeutics (SGMO) Reports Q2 Loss, Lags Revenue Estimates
Niagen Bioscience (NAGE) Q2 Earnings and Revenues Surpass Estimates
CRVO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Alnylam Pharmaceuticals (ALNY) Q2 Earnings and Revenues Beat Estimates
CERVOMED INC (CRVO) Surges 11.6%: Is This an Indication of Further Gains?
CervoMed Inc. (CRVO) Reports Q1 Loss, Tops Revenue Estimates
Other News for CRVO
Is CRVO poised for a decline? 180 Bearish Setup shows up after sinking 3.83%
Is CRVO set to breakout? NR7 shows up after climbing 3.98%
CRVO forms Lower Bollinger Band Walk on September 17
New Downtrend appears for CRVO after 5.04% move
CervoMed (CRVO) Advances Dementia Treatment with Neflamapimod